Standard Review for Biogen's BG-12Zacks.comMeanwhile, Biogen and partner Abbott (ABT – Analyst Report) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Daclizumab is being evaluated as a once-monthly or b…
Bypass Beats Angioplasty for People With Diabetes – WebMD
Bypass Beats Angioplasty for People With DiabetesWebMDThe increase in survival with bypass was significantly greater among people with diabetes, heart failure, or peripheral vascular disease (blocked blood vessels outside of the heart and brain). Smoke…
Study shows benefit of new maintenance therapy for multiple myeloma – Medical Xpress
Study shows benefit of new maintenance therapy for multiple myelomaMedical XpressA medical procedure called autologous hematopoietic stem cell transplantation, commonly known as a stem cell transplant, is frequently an important treatment option for ma…
Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive … – Sacramento Bee
Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive …Sacramento BeeSpecifically, findings showed: "Kidney transplantation is widely regarded as the 'gold standard' treatment for End Stage Renal Disease and is asso…
Revlimid Maintenance Therapy: Three Major Studies Clarify The Benefits And Risks – The Myeloma Beacon
Revlimid Maintenance Therapy: Three Major Studies Clarify The Benefits And RisksThe Myeloma BeaconIn two of the three trials, the initial treatment also included a stem cell transplant. After the initial treatment, patients were randomly assigned to ta…
Surprise Gift for New Mom: A New Heart – Newswise (press release)
Surprise Gift for New Mom: A New HeartNewswise (press release)“Vanderbilt is the only place in Nashville where this scenario could happen,” said Simon Maltais, MD, Ph.D., assistant professor of Cardiac Surgery and surgical director of Mechanical Su…
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving … – MarketWatch (press release)
New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving …MarketWatch (press release)MINNEAPOLIS & BOSTON, May 11, 2012 (BUSINESS WIRE) — Medtronic, Inc. (NYSE:MDT) today announced findings from an economic analysis of the …
Rituximab Little Use in Resistant Idiopathic Nephrotic Syndrome – Doctors Lounge
Rituximab Little Use in Resistant Idiopathic Nephrotic SyndromeDoctors LoungeThe anti-CD20 monoclonal antibody, rituximab, added to prednisone and calcineurin inhibitors, does not provide any additional benefit in terms of reduced proteinuria in the tr…
Prostate cancer drug 'too expensive' for NHS – Best Medical Cover
Telegraph.co.ukProstate cancer drug 'too expensive' for NHSBest Medical CoverBut the National Institute for Health and Clinical Excellence (NICE) deems the drug to be too pricy for use alongside prednisone or prednisolone as a second-line treat…
Watch: UCSD Sued Over Cancerous Kidney Transplant
California man claims surgeon knowingly gave him a kidney with a cyst.